Podcasts about cme

In this episode of Bowel Sounds, hosts Dr. Jenn Lee and Dr. Peter Lu  talk with Dr. Hilary Michel, pediatric gastroenterologist at Nationwide Children's Hospital in Columbus, OH about women's health in IBD. Learning objectivesIdentify the impact of inflammatory bowel disease (IBD) on key stages of female reproductive health, including puberty, menstruation, fertility, and pregnancy.Discuss the considerations and clinical decision-making involved in contraceptive counseling and bone health in female patients with IBD.Apply patient-centered strategies for addressing psychosocial concerns, fertility, and reproductive planning in adolescent and young adult females with IBD.Support the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis.  CME information and select publications here.

How do we have long careers and avoid burnout?Micah talks about burnout and how we have the advantage in emergency medicine that we can leave work at work and step backHave time off and don't work overtime every time an opportunity arises, don't only discuss work with your spouse, have other interests that you can engage inEmergency medicine is a fun job to identify with because we get to save lives, but you should not make it your whole personalityFind an identity outside of work, you may not have work at some point and life changesAudrianna talks about taking care of yourself. As we spend so much time being empathetic for others, we can lose that empathy for family or even ourselvesWe talk about the lower acuity patients we care for and infrastructure to take care of their complaint quickly from the ED, patients have poor access to primary care, and we can be that solutionWe can't use low acuity calls as something that burns us out or allows us to get frustrated, it will always be part of the job and we should view it as us being the solutionWe can be educators, we are trained to recognize emergencies, the layperson shouldn't be expected to know thisWe have the privilege of taking care of everyone regardless of complaint, ability to pay, social statusBurnout begets burnoutTake the time off when you need it, overtime takes more from you than it may be worthCertain seasons of life may necessitate working more but you have to understand the cost benefitJust making it through COVID is a victory, it burned a lot of providers out, even those with experienceWe recount some of our COVID war storiesSupport the showFull show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition Everything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions.

Clinical investigators discuss available data guiding the management of hepatocellular carcinoma.  CME information and select publications here.

Listen in as our expert panel discusses medications for the treatment of Alzheimer dementia.  They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monoclonal antibodies.  And you'll hear strategies for managing behavioral and psychological symptoms of dementia.   Special guests:Tatyana Gurvich, PharmD, BCGP, APhAssociate Professor of Clinical PharmacyMann USC School of PharmacyUCI Senior Health CenterCandace Pierce, DNP, RN, CNE, COINurse Educator, Nurse Planner, and Healthcare LeaderColibri HealthcareDarlene Moyer, MD, FAAFPAssociate Director, HonorHealth Family Medicine Residency ProgramAssociate Professor of Clinical Practice – SOMME – Arizona State UniversityClinical Associate Professor – University of Arizona College of Medicine - PhoenixYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in April 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ - Alzheimer Dementia Pharmacotherapy Chart – Pharmacotherapy of Dementia BehaviorsChart - Drugs with Anticholinergic ActivityChart - Send us a textCheck out our NEW podcasts.Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Clinical investigators discuss available data guiding the management of hepatocellular carcinoma.  CME information and select publications here.

Clinical investigators discuss available data guiding the management of multiple myeloma.  CME information and select publications here.

Highlights from AUA2025: Advances in NMIBC (2025) CME Available: https://auau.auanet.org/node/43167 At the conclusion of this CME activity, participants will be able to: 1. Recognize recent developments in the management of NMIBC. 2. Evaluate new and emerging therapies for NMIBC, such as novel intravesical agents and immunotherapies, their mechanism of action and related adverse events. 3. Employ current management approaches for NMIBC. 4. Utilize risk stratification to guide treatment decisions for NMIBC patients. 5. Implement diagnostic techniques for NMIBC, including cystoscopy, urine cytology, biomarkers, and advanced imaging modalities. This educational activity is supported by independent educational grants from: Merck & Co., Inc. ImmunityBio, Inc.

Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. CME information and select publications here.

CME credits: 0.50 Valid until: 30-05-2026 Claim your CME credit at https://reachmd.com/programs/cme/obesity-unmasking-the-chronic-disease-beneath-the-weight/35826/ This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www.allaboutobesity.org

CME credits: 0.50 Valid until: 30-05-2026 Claim your CME credit at https://reachmd.com/programs/cme/practical-tips-for-glp-1-ra-therapy-success/35830/ This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www.allaboutobesity.org

CME credits: 0.50 Valid until: 30-05-2026 Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-scale-how-to-tackle-obesitys-comorbidities/35829/ This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www.allaboutobesity.org

CME credits: 0.50 Valid until: 30-05-2026 Claim your CME credit at https://reachmd.com/programs/cme/treating-obesity-lifelong-strategies-from-lifestyle-to-pharmacotherapy-and-surgery-treating-obesity-lifelong-strategies-ffrom-lifestyle-to-pharmacotherapy-and-surgery/35828/ This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www.allaboutobesity.org

CME credits: 0.50 Valid until: 30-05-2026 Claim your CME credit at https://reachmd.com/programs/cme/obesity-and-comorbidities-strategies-for-effective-patient-management/35827/ This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www.allaboutobesity.org

Are you unsure how to articulate your reasons for wanting a new job without sounding negative or unprofessional? Do you want to confidently explain situations like seeking growth, changing careers, or even a layoff? This episode will help you: Understand the two essential parts of an effective exit statement Learn how to frame common reasons for leaving Discover crucial things to avoid sayingBy the end of this episode, listeners will learn how to prepare and deliver an honest, brief, and positive exit statement that reassures potential employers, highlights their skills, and effectively positions them for their next career move.  In this Episode:  [4:09] Changing, growing, or letting go? [10:03] Get your list of questions right here [15:14] Shhh – don't say these things outloud  Links and Resources:  Industry Insider - 12 hours of CME, learn exactly how to land a rewarding nonclinical career without a new degree, special connections, prior experience, or a pay cut  Support the show

Jess Britt is an executive coach and consultant who partners with leaders across sectors to transform their organizations through systematic approaches to managing people and work. She specializes in empowering senior leaders and teams in complex, dynamic environments to build collaborative, high-performing, data-driven workplace cultures using a facilitative leadership approach. As recently featured on the Coaching for Leaders podcast, she joins us to share practical tips for leading engaging and effective meetings drawing from her executive leadership and nonprofit board chair experience. Learn more about Jess at www.jessbritt.com. Reach out to Jess at jess@jessbritt.com sharing one thing you tried from this conversation and she'll send you more of her tips for leading engaging and effective meetings.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.

How can continuing education break down professional silos and foster real collaboration among healthcare teams? If you create CME/CE content, you've likely encountered the challenge of writing for “teams” that still operate in silos. This episode with interprofessional education expert Dr. Tina Patel Gunaldo, Founder, Collaborate for Health, reveals why just using the term “team-based care” isn't enough—and how content creators can more accurately reflect the evolving nature of healthcare collaboration. As patient-centered models expand and asynchronous care becomes the norm, CME professionals need a deeper understanding of roles, language, and practice contexts to design impactful education. Discover the critical differences between interprofessional, interdisciplinary, and multidisciplinary practice—and why it matters for CME writing. Learn how to structure education that empowers team collaboration and respects the unique contributions of each discipline. Understand the growing role of patients, technology, and asynchronous communication in shaping interprofessional collaboration today. And if you're unsure when to use “interprofessional” vs “multidisciplinary”? We've got you covered. We created a one-page Quick Reference Guide to help you use team-based language precisely and avoid common traps in CME writing. It's perfect for writers, educators, and reviewers who want to level up their clarity. Grab the download in the show notes and keep it handy as you create your next piece of content. Tune in now to learn how you can write CME content that reflects real-world collaboration—and elevates both learner experience and patient care outcomes. Connect with Tina Website: https://collaborateforhealth.com LinkedIn Interprofessional Terms Quick Reference Guide

Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.

The CME's 13th birthday is coming up, and you know what that means: it's pledge month! Now through June 1, get 50% off a new monthly or annual Patreon subscription when you use the code CME13 at checkout! Get on it! Join the team! Support the community! Stick it to the man! Merab Dvalishvili broke his toe on the dome of a training partner this week, which seems like poor timing, considering his men's bantamweight title defense against Sean O'Malley is coming right up at UFC 316 on June 7. When your game plan hinges at least partially on your unstoppable takedowns, that seems like it could potentially be a big deal. No worries, though. The always irrepressible Merab points out that he's got nine more toes, so if he needs to cut this one off in order to fight O'Malley, so be it. For O'Malley, did foot stomps just become a big part of the strategy? Plus, Vitor Belfort is going in the hall, Nate Diaz is back in the news and is the MMA world ready for Ciryl Gane — leading man? Learn more about your ad choices. Visit megaphone.fm/adchoices

Skin of Color Issues - with Dr. Tia Paul! -Anterior cervical hypertrichosis -A new vascular anomaly: SeCVAUS -Can you just observe SCCis? -Early inflammatory morphe can mimic port-wine stains -Learn more about Dr. Paul at balancedskin.com/ or on Instagram/Tiktok @dr.tiapaul!Join Luke's CME experience on Jak inhibitors! ⁠rushu.gathered.com/invite/ELe31Enb69⁠Register for the U of U Practical Derm course!⁠medicine.utah.edu/dermatology/educ…ities/practical⁠Learn more about the U of U Dermatology ECHO model!⁠physicians.utah.edu/echo/dermatology-primarycare⁠Want to donate to the cause? Do so here!
Donate to the podcast: ⁠uofuhealth.org/dermasphere⁠
Check out our video content on YouTube:
⁠www.youtube.com/@dermaspherepodcast⁠
and VuMedi!: ⁠www.vumedi.com/channel/dermasphere/⁠
The University of Utah's Dermatology
ECHO: ⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠ -
⁠ Connect with us!
- Web: ⁠⁠dermaspherepodcast.com/⁠⁠ - Twitter: @⁠DermaspherePC⁠
- Instagram: dermaspherepodcast
- Facebook: ⁠www.facebook.com/DermaspherePodcast/⁠
- Check out Luke and Michelle's other podcast,
SkinCast! ⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our
friends at:
- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)
- ⁠⁠www.levelex.com/games/top-derm⁠⁠ (A free dermatology game to learn
more dermatology!

Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, MD, including the following topics: Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — Dr Janjigian (0:00) Available and Emerging Targeted Therapeutic Approaches for Gastroesophageal Cancers — Dr Klempner(28:38) CME information and select publications

In episode 60 we discuss treating methamphetamine use disorder with lisdexamfetamine (Vyvanse). Ezard N, et al; The LiMA Investigator Group. Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Addiction. 2024 Dec 19. We also discuss why some people don't get hangovers, and tianeptine, otherwise known as gas station heroin. New York Times:The People Who Never Get Hangovers Pain Therapeutics:Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music:composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer:Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Clinical investigators discuss available data guiding the management of gastroesophageal cancer.  CME information and select publications here.

Clinical investigators discuss available data guiding the management of gastroesophageal cancer.  CME information and select publications here.

Featuring an interview with Dr Lindsey Roeker, including the following topics: Clinical development of novel Bruton tyrosine kinase (BTK) degraders in therapy for chronic lymphocytic leukemia (CLL) (0:00) Safety of BTK inhibitors in older and frail patients with CLL (3:41) Utility of minimal residual disease-guided treatment with venetoclax/obinutuzumab (9:20) Impact of the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab in CLL (16:32) Utility of acalabrutinib, venetoclax and obinutuzumab for high-risk CLL (23:31) Emerging data with sonrotoclax and zanubrutinib in treatment-naïve CLL (25:16) Sequencing, tolerability and future development involving pirtobrutinib (25:57) Emerging data with the addition of a BTK inhibitor to chimeric antigen receptor T-cell therapy (32:28) Clinical considerations in the management of Richter's transformation (38:14) Survival outcomes and quality of life for patients with CLL (41:02) Ongoing and future efforts to improve CLL treatment outcomes (45:01) CME information and select publications  

Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.

How do we handle the sensitive hand-off reports from EMS to the ED?Different aspects, like potentially violent family members, unsafe scenes, are often a critical details that need to be conveyed to the ED but don't have to be announced to everyone in the hand-off report in front of the patientMicah works as a field and ER paramedic. He talks about this situation and how it's going for him. He enjoys the number of resources he has access to in the EDBeing able to see the whole workup and outcome of the patient is a big benefit as well, working in the EDI love it when the EMS crews come back and follow up on their patients, it's a big way to help them improve and learnWe talk about interpersonal conflict on scenesCasey tries to be as friendly as he can and learn everyone's namesIt's easy for all of us to allow our egos to get too out of hand, but we need to treat everyone how we would want to be treatedI talk about some issues I've had with the fire department in the past – sometimes it is all about how you are doing something as opposed to what you are doing in your interactions with other agenciesAt the end of the day, the patient can be affected when we have confrontational scenes so we should always be seeking to avoid thisAlex talks about working 48 hours with his fire crew and responding on scenes with the same crew and how this differs from private ambulance responding with other agencies he may not know very wellCasey talks about how, years ago, the EMS crews had more time to stop by the fire stations and become more familiar with the fire crewsCasey talks about the power of edifying others in our fieldAudrianna talks about a fire crew going above and beyond in the ED as wellWe talk about small things we can all do to go above and beyond our regular tasks, helping families navigate the ED, getting a blanket for someone, cleaning a roomLittle things like this also help you feel better about your job too; they help you remember why you got into medicine in the first placeIt does require you to look beyond yourself to see those opportunitiesSupport the showFull show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition Everything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions.

Featuring a slide presentation and related discussion from Dr Lindsey Roeker, including the following topics: Recent clinical updates with standard regimens for chronic lymphocytic leukemia (CLL) (0:00) Utility of minimal residual disease-guided treatment intensification after ibrutinib with venetoclax  (7:03) Major long-term findings from the GLOW study of ibrutinib with venetoclax (10:35) Principal findings from the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab (12:28) Findings with combined acalabrutinib, venetoclax and obinutuzumab for patients with previously untreated high-risk disease  (15:52) Early clinical findings with sonrotoclax and zanubrutinib as front-line treatment for CLL (18:12) Principal findings from the BRUIN CLL-321 trial of pirtobrutinib for patients who previously received a covalent Bruton tyrosine kinase (BTK) inhibitor  (19:38) Emerging evidence with pirtobrutinib, venetoclax and obinutuzumab as front-line treatment  (22:15) Novel strategy combining lisocabtagene maraleucel with ibrutinib for relapsed/refractory (R/R) CLL (24:13) Available data with epcoritamab monotherapy for R/R CLL  (26:58) The emerging pharmacologic class of BTK degraders  (29:04) CME information and select publications

In our second drop of the week, Ashley sits down with Alison Coughlin from the CME Group to unpack the newly launched Southern Yellow Pine (SYP) Lumber Futures contract. It's been live for over a month now, and we're breaking down how it came to be, how it works, and why it could be a game-changer for the fastest-growing segment in U.S. lumber production. Whether you're a trader, mill, or just lumber-curious, this episode offers a smart intro into what the new contract means for the market—and how you can get involved. To learn more, check out https://www.cmegroup.com/markets/agriculture/lumber-and-softs/southern-yellow-pine.html, or shoot a note to the CME team at Lumber@CME.com. To sign up for Fastmarkets' “Daily Southern Yellow Pine” Newsletter, click here: https://www.fastmarkets.com/forest-products/wood-products/southern-yellow-pine/ For more information on The Lumber Word” or to drop us a note, visit us at https://www.thelumberchannel.com/

Featuring a slide presentation from Dr Matthew Matasar and related discussion from Dr Carla Casulo, Dr Matasar and Dr Laurie H Sehn, including the following topics: EZH2 Inhibitors for Follicular Lymphoma (FL) (0:00) Bruton Tyrosine Kinase Inhibitors for FL (5:43) Anti-CD19 Antibodies for FL (9:40) Other Novel Agents Under Clinical Development for FL (18:50) Case: A woman in her early 80s with multiple comorbidities and relapsed FL (23:06) Case: A man in his early 40s with high-risk progressive FL that did not achieve deep remission with prior therapy (27:07) Case: A woman in her early 70s with rheumatoid arthritis and relapsed FL (33:46) CME information and select publications

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.

James R. Korndorffer Jr., M.D., MHPE, FACS, joined the University of Texas Austin, Dell Medical School in January of 2025 and leads the continuum of medical education to train the next generation of physicians and health care professionals. In addition, he leads efforts across The University of Texas at Austin and The University of Texas System to support interprofessional education, curricular innovation, research and other learning activities.Korndorffer graduated cum laude from Tulane University with an undergraduate degree in biomedical engineering. He received his medical degree from the University of South Florida College of Medicine. He completed his general surgery internship and residency at the Carolinas Medical Center in Charlotte, North Carolina, where he received the award for best resident teacher.With a strong interest in teaching, Korndorffer left a successful private practice after eight years and joined the faculty at Tulane University School of Medicine He became an associate professor of surgery in 2005 and professor in 2010. He served in numerous leadership roles at Tulane, including vice chair of the surgery department from 2012 to 2017, program director for the surgical residency from 2006 to 2017, assistant dean for graduate medical education and founding medical director for the Tulane Center for Advance Medical Simulation. Continuing his passion for education, Korndorffer completed his Master of Health Professions Education at the University of Illinois Chicago while working full time at Tulane.Korndorffer joined Stanford School of Medicine's Department of Surgery as the inaugural vice chair for education in 2017. He assumed additional leadership responsibilities within the department, including director of the Goodman Surgical Simulation Center and the surgical education fellowship program.He was one of the early adopters of the use of simulation for surgical training and has been actively involved in surgical education research since 2003. Some of the early work using proficiency-based training instead of time base training for skill acquisition. This has now become the norm. He is now actively involved investigating the role simulation education has in patient quality and healthcare system safety.Korndorffer has published over 100 papers in peer-reviewed journals as well as 10 book chapters, and he has held over 150 presentations at national and international meetings.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Featuring perspectives from Dr Shilpa Gupta and Dr Jonathan E Rosenberg, including the following topics: Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Gupta (0:00) Optimizing the Treatment of Metastatic UBC — Dr Rosenberg (21:52) CME information and select publications

Clinical investigators discuss available data guiding the management of urothelial bladder cancer.  CME information and select publications here.

In this episode, Tom Varghese, MD, FACS, is joined by Todd Heniford, MD, FACS, and Alexis Holland, MD, from the Carolinas Medical Center. They discuss the recent article by Drs Heniford and Holland, “Limited or Lasting: Is Preoperative Weight Loss as Part of Prehabilitation Maintained after Open Ventral Hernia Repair?” This study supports the implementation of preoperative optimization and weight loss before hernia surgery, which remains controversial. Long-term maintenance of preoperative weight loss before abdominal wall reconstruction is achievable and sustainable.   Disclosure Information: Drs Varghese and Holland have nothing to disclose. Dr Heniford is a surgical research grant recipient and receives speaking honoraria from WL Gore.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Crypto News: Blackrock continues to buy huge amounts of Bitcoin for its ETF IBIT. Ethereum traders targeting $6K price. XRP futures day one beats solana's on CME.Show Sponsor -

Featuring perspectives from Dr Paul E Oberstein and Dr Philip A Philip, including the following topics: Selection and Sequencing of Therapy for Patients with Metastatic Pancreatic Adenocarcinoma (PAD) — Dr Oberstein (0:00) Biomarker-Based Strategies for Metastatic PAD; Novel Investigational Approaches — Dr Philip(30:57) CME information and select publications

Are you unsure which skills you need to thrive as a CME writer (or need for your writers)—or how to prove your value in an increasingly competitive field? Many medical writers stumble into CME with strong writing chops but little clarity about what the role truly demands. At the same time, education providers struggle to find writers who are not just capable—but competent. This episode bridges that gap. Don Harting and Haifa Kassis join us to unpack the results of their groundbreaking Delphi study on CME writing competencies, revealing what hiring managers really want and how you can grow your career strategically. In this episode, you'll learn: The four core competencies every CME writer should master today Which deliverables are in high demand—and which are vanishing How this competency model can support onboarding, training, and upskilling. Press play to learn how to align your writing skills with what the CME industry actually needs—so you can stand out, get hired, and grow with confidence. Resources Kassis, H., & Harting, D. (2024). Medical Writing for Continuing Education in the Health Professions: A Competency Model. Journal of CME, 13(1). https://doi.org/10.1080/28338073.2024.2422709 CME Writers' Toolbox Delphi Panelists WriteCME Pro: Accelerate your freelance CME writing business growth Timestamps 00:00 Introduction to CME Writing Challenges 00:20 Meet the Researchers: Haifa Kassis and Don Harting 01:19 The Competency Model: Key Findings 02:40 Expert Consensus and Methodology 06:16 Surprising Insights and Real-World Challenges 11:15 Practical Applications and Future Directions 24:35 Emerging Competencies and Industry Trends 28:47 Conclusion and Contact Information

Neuro-ophthalmic deficits significantly impair quality of life by limiting participation in employment, educational, and recreational activities. Low-vision occupational therapy can improve cognition and mental health by helping patients adjust to visual disturbances. In this episode, Katie Grouse, MD, FAAN, speaks with Sachin Kedar, MD, FAAN, author of the article “Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances” in the Continuum® April 2025 Neuro-ophthalmology issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Kedar is the Cyrus H Stoner professor of ophthalmology and a professor of neurology at Emory University School of Medicine in Atlanta, Georgia. Additional Resources Read the article: Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @AIIMS1992 Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, and please introduce yourself to our audience. Dr Kedar: Thank you, Katie. This is Sachin Kedar. I'm a neuro-ophthalmologist at Emory University, and I've been doing this for more than fifteen years now. I trained in both neurology and ophthalmology, with a fellowship in neuro-ophthalmology in between. It's a pleasure to be here. Dr Grouse: Well, we are so happy to have you, and I'm just so excited to be discussing this article with you, which I found to be a real treasure trove of useful clinical information on a topic that many find isn't covered enough in their neurologic training. I strongly recommend all of our listeners who work with patients with visual disturbances to check this out. I wanted to start by asking you what you hope will be the main takeaway from this article for our listeners? Dr Kedar: The most important takeaway from this article is, just keep vision on your radar when you are evaluating your patients with neurological disorders. Have a list of a few symptoms, do a basic screening vision, and ask patients about how their vision is impacting the quality of life. Things like activities of daily living, hobbies, whether they can cook, dress, ambulate, drive, read, interact with others. It is very important for us to do so because vision can be impacted by a lot of neurological diseases. Dr Grouse: What in the article do you think would come as the biggest surprise to our listeners? Dr Kedar: The fact that impairment of vision can magnify and amplify neurological deficits in a lot of what we think of as core neurological disorders should come as a surprise to most of the audience. Dr Grouse: On that note, I think it's probably helpful if you could remind us about the types of visual disturbances we should be thinking about and screening for in our patients? Dr Kedar: Patients who have neurological diseases can have a whole host of visual deficits. The simplest ones are deficits of central vision. They can have problems with their visual field. They can have abnormalities of color vision or even contrast sensitivity. A lot of our patients also complain of light sensitivity, eyes feeling tired when they're doing their usual stuff. Some of our patients can have double vision, they can have shaky vision, which leads to their sense of imbalance and maybe a fall risk to them. Dr Grouse: It's really helpful to think about all the different aspects in which vision can be affected, not just sort of the classic loss of vision. Now, your article also serves as a really important reminder, which you alluded to earlier, about how impactful visual disturbances can be on daily activities. Could you elaborate a little further on this, and particularly the various domains that can be affected when there are visual disturbances present? Dr Kedar: So, when I look at how visual disturbances affect quality of life, I look at two broad categories. One is activities of basic daily living. These would be things like, are you able to cook? Are you able to ambulate not just in your home, but in your neighborhood? Are you able to drive to your doctor's appointment or to visit with your family? Are you able to dress yourself appropriately? Are you able to visualize the clothing and choose them appropriately? And then the second category is recreational activities. Are you able to read? Are you able to watch television? Are you able to visit the theatre? Are you able to travel? Are you able to participate in group activities, be it with your family or be it with your social group? It is very important for us to ask our patients if they have problems doing any of this because it really can adversely impact the quality of life. Dr Grouse: I think, certainly with all the things we try to get through talking with our patients, this may not be something that we do spend a lot of time on. So, I think it's it is a good reminder that when we can, being able to ask about these are going to be really important and help us hit on a lot of other things we may not even realize or know to ask about. Now, I was really struck when I was reading your article by the meta-analysis that you had quoted that had showed 47% higher risk of developing dementia among the visually impaired compared to those without visual impairments. Should we be doing more in-depth visual testing on all of our patients with cognitive symptoms? Dr Kedar: This is actually the most interesting part of this article, and kind of hones in on the importance of vision in neurological disorders. Now I want to clarify that patients with visual disorders, it's not a causative influence on dementia, but if you have a patient with an underlying cognitive disorder, any kind of visual disturbance will significantly make it worse. And this has been shown in several studies, both in the neurologic and in the ophthalmological literature. So, I quoted one of the big meta-analysis over there, but studies have clearly shown that if you have these patients and treat them for their visual deficits, their cognitive indices can actually significantly improve. To answer your question, I would say a neurologist should include basic vision screening as part of every single evaluation. Now, I know it's a hard thing in, you know, these days when we are literally running on the hamster wheel, but I can assure you that it won't take you more than 2 to 3 minutes of your time to do this basic screening; in fact, you can have one of your assistants included as part of the vital signs assessment. What are these basic screening tools? Measure the visual acuity for both near and distance. Check and see if their visual field's off with the confrontation. Look at their eye movements. Are they able to move their eyes in all directions? Are the eyes stable when they're trying to fixate on a particular point? I think if you can do these basic things, you will have achieved quite a bit. Dr Grouse: That's really helpful, and thanks for going through some of the standard, or really, you know, solid basic foundation of visual testing we should be thinking about doing. I wanted to move on to some more details about the visual disturbances. You made an excellent point that there are many types of primary ophthalmologic conditions that can cause visual disturbances that we should keep in mind. So maybe not things that we think about a lot on a day-to-day basis, but, you know, are still there and very common. What are some of the most common ones, and when should we be referring them to see an ophthalmologist? Dr Kedar: So, it depends on the age group of your patient population. Now, the majority of us are adult neurologists, and so the kinds of ophthalmic conditions that we see in this population is going to be different from the pediatric age group. So in the adult population, we might see patients with uncorrected refractive error, presbyopia, patients who have cataracts creep on them, they may have glaucoma, they may have macular degeneration, and these tend to have a slightly higher incidence in the older age group. Now for those of us who are taking care of the younger population, uncorrected refractive errors, strabismus and amblyopia tend to be fairly common causes of visual deprivation in this age group. What I would encourage all of our neurologists is, make sure that your patients get a basic eye examination at least once a year. Just like you want them to go to their primary care and get an annual maintenance visit, everybody should go to the ophthalmologist or the optometrist and get a basic examination. And, if you're resourceful enough, have your patients bring a copy of that assessment. Whether it is normal or there's some abnormality, it is going to help you in the management. Dr Grouse: Absolutely. I think that's a great piece of advice, to think of it almost, like, them seeing their primary care doctor, which of course we offer encourage our patients to do, thinking of this as another very important piece of standard primary care. If a patient comes to you reporting difficulty reading due to possible visual disturbances, I'm curious, can you walk us through how you would approach this evaluation? Dr Kedar: It is not a very common presenting complaint of our patients, even in the neuro-ophthalmology clinic. It's a very rare patient that I see who comes and says, I cannot read or, I have difficulty reading. Most of the patients will come saying, oh, I cannot see. And then you have to dig in to find out, what does that actually mean? What can you not see? Is it a problem in your driving? Is it a problem in your reading? Or is it a problem that occurs at all times? Now you asked me, how do you approach this evaluation? One of the things that all of us, whether we are neurologists, ophthalmologists, or neuro-ophthalmologists, forget to do is to actually have the patient read a paragraph, a sentence, when they are in clinic. And that will give you a lot of ideas about what might actually be going wrong with the patient. Now, as far as how do I approach this evaluation, I will do a basic screening examination to make sure that their visual acuity is good for both distance and near. A lot of us tend to do either distance or near and we will miss the other parameter. You want to do a basic confrontation visual field to make sure that they do not have any subtle deficits that's impacting their ability to read. Examine the eye movements, do a fundoscopic examination. Now, once you've done this basic screening, as a neurologist, you already have some idea of whether your patient has a lesion along the visual pathways. If you suspect that this is a problem with, say, the visual pathways, ask your ophthalmology colleague to do a formal visual field assessment, and that'll pick up subtle deficits of central visual field. And lastly, don't forget higher visual function testing or cortical visual function testing. So basically, you're looking for neglect, phenomenon, or simultanagnosia, all of which tends to have an impact on reading. So, in the manuscript I have a schema of how you can approach a patient with reading difficulties, and in that ischemia you will see categories of where things can go wrong during the process of reading. And if you can approach your patient systematically through one of those domains, there's a fairly good chance that you'll be able to pick up a problem. Dr Grouse: Going a little further on to when you do identify problems with loss of central or peripheral vision, what are some strategies for symptomatic management of these types of visual disturbances? Dr Kedar: As a neurologist, if you pick up a problem with the vision, you have to send this patient to an eye care provider. The vast majority of people who have visual disturbances, it's from an eye disease. You know, as I alluded to earlier, it can be something as simple as uncorrected refractive error, and that can be fixed easily. A lot of patients in our older age group will have dry eye syndrome, which means they are unable to adequately lubricate the surface of the eye, and as a result, it degrades the quality of their vision. So, they tend to get intermittent episodes of blurred vision, or they tend to get glare. They tend to get various forms of optical aberration. Patients can have cataracts, patients can have glaucoma or macular degeneration. And in all of those instances, the goal is to treat the underlying disease, optimize the vision, and then see what the residual deficit is. By and large, if a patient has a problem with the central vision, then magnification will help them for activities that they perform at near; say, reading. Now for patients with peripheral vision problem, it's a different entity altogether. Again, once you've identified what the underlying cause is, your first goal is to treat it. So, for example, if your patient has glaucoma, which is affecting peripheral vision, you're going to treat glaucoma to make sure that the visual field does not progress. Now a lot of what happens after that is rehabilitation, and that is always geared towards the specific activities that are affected. Is it reading? Is it ambulating? Is it watching television? Is it driving? And then you can advise as a neurologist, you can advise your occupational therapist or low vision specialist and say, hey, my patient is not able to do this particular activity. Can we help them? Dr Grouse: Moving on from that, I wanted to also hit on your approach when patients have disorders of ocular motility. What are some things you can do for symptomatic management of that? Dr Kedar: So, patients with ocular motility can have two separate symptoms. Two, you know, two disabling symptoms, as they would call it. One is double vision and the other is oscillopsia, or the feeling or the visualization of the environment moving in response to your eyes not being able to stay still. Typically, you would see this in nystagmus. Now, let's start with diplopia. Diplopia is a fairly common presenting complaint for neurologists, ophthalmologists, and the neuro-ophthalmologist. The first aspect in the management of diplopia is to differentiate between monocular diplopia and binocular diplopia. Now, monocular diplopia is when the double vision persists even after covering one eye. And that is never a neurological issue. It's almost always an ophthalmic problem, which means the patient will then have to be assessed by an eye care provider to identify what's causing it. And again, refractive error, cataracts, opacities, they can do it. Now, if the patient is able to see single vision by covering one eye at a time, that's binocular diplopia. Now, in patients with binocular diplopia in the very early stages of the disease, the standard treatment regimen is just monocular occlusion. Cover one eye, the diplopia goes away, and then give it time to improve on its own. So, this is what we would typically do in a patient with, say, acute sixth nerve palsy or fourth nerve palsy or third nerve palsy, maybe expect spontaneous improvement in a few months. Now if the double vision does not improve and persists long term, then the neuro-ophthalmologist or the ophthalmologist will monitor the amount of deviation to see if it fluctuates or if it stays the same. So, what are the treatment options that we have in a patient who absolutely refuses any intervention or is not a candidate for any intervention? Monocular occlusion still remains the viable option. Now, patients who have stable ocular deviation can benefit from using prisms in their glasses, or they can be sent to a surgeon to have a strabismus surgery that can realign their eyes. So, again, a broad answer, but there are options available that we can use. Dr Grouse: Thank you for that overview. I think that's just really helpful to keep in mind as we're working with these patients and thinking about what their options are. And then finally, I wanted to touch on patients with higher-order vision processing and attention difficulties. What are some strategies for them? Dr Kedar: These are frankly the most difficult patients that I get to manage in my clinic, simply because there is no effective therapies for managing them. In fact, I think neurologists are far better at this than ophthalmologists or even neuro-ophthalmologists. In patients with attentional disorders, everything boils down to the underlying cause, whether you can treat it or whether it is a slowly progressive, you know, condition, such as from neurodegenerative diseases. And that tailors our goals towards therapy. The primary goal is for safety. A lot of these patients who have visual disturbances from vision processing or attention, they are at accident and fall risk. They have problems with social interactions. And, importantly, there is a gap of understanding of what's going on, not just from their side but also from the family's side. So, I tend to approach these patients from a safety perspective and social interaction perspective. Now, I have a table listed in the manuscript which will go into details of what the specific things are. But in a nutshell, if your patient has neglect in a specific part of the visual field, they have accident risk on that side. Simple things like walking through a doorway, they can hurt their shoulders or their knees when they bang into the wall on that side because they are unable to judge what's on the other side. Another example would be a patient who has simultanagnosia or a downgaze policy, such as from progressive super nuclear policy. They are unable to look down fast enough, or they are simply unable to look down and appreciate things that are on the floor, and so they can trip and fall. Walking downstairs is also not a huge risk because they are unable to judge distances as they walk down. A lot of what we see in these patients are things that we have to advise occupational therapists and help them improve these safety parameters at home. Another thing that we often forget is patients can inadvertently cause a social incident when they tend to ignore people on their affected side. So, if there is a family gathering, they tend to consistently ignore a group of people who are sitting on the affected side as opposed to the other side. And I've had more than a few patients who've come and said that, I may have offended some of my friends and family. In those instances, it's always helpful when they are in clinic to demonstrate to the family how this can be awkward and how this can be mitigated. So, having everybody sit on one side is a useful strategy. Advise your family and friends before a gathering that, hey, this may happen. And it is not because it is deliberate, but it's because of the medical condition. And that goes a lot, you know, further in helping our patients come out of social isolation because they are also afraid of offending people, you know. And they can also participate socially, and it can overall improve their quality of life. Dr Grouse: That's a really helpful tip, and something I'll keep in mind with my patients with neglect and visual field cuts. Thank you so much for coming to talk with us today. Your article has been so helpful, and I urge everybody listening today to take a look. Dr Kedar: Thank you, Katie. It was wonderful talking to you. Dr Grouse: I've been interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this Heartline Echo Episode, Dr. Shikha Jain discusses her journey into medicine and her multifaceted career. The conversation highlights systemic changes needed in healthcare, such as pay transparency, diverse leadership, and supporting women's career development. Dr. Jain emphasizes the importance of personal joy, career advancement, and family balance in her professional decisions, offering insights into navigating a demanding field while driving meaningful change. Join Dr. Shikha Jain on this inspiring journey as she shares her insights, strategies, and unwavering passion for creating a more equitable future for women in medicine. Immerse yourself in a conversation that promises to ignite your own inner fire, challenging you to embrace your authentic voice and become an agent of positive transformation. "We have to realize that we need to make decisions, even if people are going to keep asking us to do stuff because we're good at what we do. At some point, you have to say no because it's not worth it." -Dr. Shikha Jain As a GI oncologist, Director of Communication Strategy at the University of Illinois Cancer Center, and the founder of the Women in Medicine Summit, Dr. Jain has dedicated herself to a mission that transcends mere professional development. Her unwavering commitment lies in dismantling the very foundations that have hindered women's progress, paving the way for a healthcare ecosystem that truly embraces equity, diversity, and inclusivity. In this thought-provoking conversation, you'll discover: Innovative strategies to address systemic barriers, such as pay transparency, diverse leadership pipelines, and supportive career pathways. The transformative impact of the Women in Medicine Summit, a premier CME conference that equips attendees with practical skills, personal growth opportunities, and a powerful network of allies. Register here. Insights into Dr. Jain's personal journey, from her early inspiration to her relentless pursuit of empowering women and driving positive change within healthcare systems. The Resources Mentioned in this episode are: Visit Dr. Shikha Jain's ⁠website⁠ to learn more about her and to check out her ⁠podcast⁠.  Register for the ⁠Women in Medicine Summit⁠ occurring September 13th to 14th at the Drake Hotel in Chicago and consider attending the ⁠2025 Women in Medicine European River Retreat⁠. Connect with Dr. Shikha Jain: ⁠X⁠ ⁠LinkedIn⁠ ⁠Facebook⁠ ⁠Instagram⁠

The CME's 13th birthday is this month, and you know what that means: It's pledge month! Now through June 1, GET 50% OFF A NEW MONTHLY OR ANNUAL PATREON SUBSCRIPTION when you use the code CME13 at checkout! Get on it! Join the team! Support the community! Stick it to the man! First you've got Jon Jones riding on the back of a motorbike looking zooted out of his gourd over there in Thailand. Then you've got Jones riding his own motorbike, saying he's “living his best life” on Instagram Live while zigzagging around parked cars. Now you've got Jones replying to random dudes on Twitter (like he does) about how much he doesn't care about potentially getting stripped of the UFC heavyweight title (sure, Jon), and declaring he “told the UFC about his plans” a long time ago. All Jones cares about now, he says, is monetizing the brand he's built — which … I mean … isn't the Jon Jones Brand shooting your gun off outside the strip club and having car wrecks with pregnant ladies? How exactly is he “monetizing” that “brand” from the back of a motorbike in Thailand? Plus, everybody's washed at welterweight all of a sudden, and Ilia Topuria parts ways with his longtime coaches and trainers … WAIT, WHAT? Learn more about your ad choices. Visit megaphone.fm/adchoices

Crypto News: The Stablecoin Bill Genius Act gets vote to move to the next phase in Senate. JPMorgan to allow clients to buy Bitcoin, CEO Jamie Dimon says. Singapore dollar-pegged stablecoin gets launched on the XRP ledger.Show Sponsor -

Featuring an interview with Dr Jennifer Crombie, including the following topics: Overview of similarities and differences among CD20 x CD3 targeted bispecific antibodies for the treatment of lymphomas (0:00) Optimal integration of CD20 x CD3 bispecific antibodies into treatment algorithms for lymphomas (9:40) Case: A man in his late 60s with relapsed follicular lymphoma (FL) who received mosunetuzumab (23:52) Case: A man in his late 80s with transformed, double-hit diffuse large B-cell lymphoma (DLBCL) who received epcoritamab (28:46) Case: A woman in her early 70s with recurrent FL who received odronextamab on the ELM-1 trial (34:06) Case: A man in his early 80s with multiregimen-relapsed DLBCL who receives glofitamab (43:19) CME information and select publications

Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas. CME information and select publications here.

In this episode of Bowel Sounds, hosts Dr. Jenn Lee and Dr. Peter Lu  talk with Dr. Nishant Patel, pediatric gastroenterologist at Orlando Health Arnold Palmer Hospital for Children, about the diagnosis and evaluation of exocrine pancreatic insufficiency (EPI) in children. Learning objectivesRecognize the varied clinical presentations of exocrine pancreatic insufficiency (EPI)Compare the utility, advantages, and limitations of diagnostic tools for EPIApply evidence-based protocols for performing and interpreting ePFTEndoscopic Pancreatic Function Testing (ePFT) in Children: A Position Paper From the NASPGHAN Pancreas CommitteeSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

For this Med Student Over Easy episode, Patricia is joined by Tanner and guest Mary McLean to discuss the topic of Medical Holds and what medical students need to know about taking care of the in the ED. Don't forget, our mother show EM Over Easy is the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn about an upcoming CME event.

Featuring an interview with Dr Rinath M Jesselsohn, including the following topics: Imlunestrant with or without abemaciclib in advanced breast cancer: Results of the Phase III EMBER-3 trial (0:00) Jhaveri KL et al. Imlunestrant with or without abemaciclib in advanced breast cancer. N Engl J Med 2025;392(12):1189-202. Abstract  Jhaveri KL et al. Imlunestrant, an oral selective estrogen receptor degrader (SERD), as monotherapy & combined with abemaciclib, for patients with ER+, HER2- advanced breast cancer (ABC), pretreated with endocrine therapy (ET): Results of the Phase 3 EMBER-3 trial. San Antonio Breast Cancer Symposium 2024;Abstract GS1-01. Comprehensive genomic profiling of ESR1, PIK3CA, AKT1 and PTEN in HR-positive, HER2-negative metastatic breast cancer: Prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice (7:00) Bhave MA et al. Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: Prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice. Breast Cancer Res Treat 2024;207(3):599-609. Abstract Camizestrant, a next-generation oral selective estrogen receptor degrader (SERD), versus fulvestrant for postmenopausal women with estrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): A multi-dose, open-label, randomized, Phase II trial (10:25) Oliveira M et al. Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): A multi-dose, open-label, randomised, phase 2 trial. Lancet Oncol 2024;25(11):1424-39. Abstract Latest on SERDs: An education session at San Antonio Breast Cancer Symposium 2024 (13:57) Jeselsohn RM. Latest on selective estrogen receptor degraders (SERDs). San Antonio Breast Cancer Symposium 2024;Education Session 5. CME information and select publications